SCHEMBL798743

SCHEMBL798743

CC(P(C1CCCCC1)C1CCCCC1)P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.31
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19464111 1.00 SHBG (0.31) SHBGADH1BADH1CADH1A
SCHEMBL17260573 0.97
Hydrochloric Acid SCHEMBL3338470 0.95
SCHEMBL29521645 0.90
SCHEMBL3338468 0.90 GAA (0.30)
SCHEMBL28235331 0.90
SCHEMBL23832132 0.82 SHBG (0.31) SHBGADH1BADH1CADH1A
SCHEMBL6032750 0.82 SHBG (0.31) SHBGADH1BADH1CADH1A
SCHEMBL6032316 0.82 SHBG (0.31) SHBGADH1BADH1CADH1A
SCHEMBL301558 0.82 SHBG (0.31) SHBGADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids UNIV COLORADO REGENTS (US) 2026-01-29 US claimed
US-12331159-B2 Polyesters and polyketoesters from carbonylative terpolymerization of enols, methods to produce, blends, and articles therefrom EXXON MOBIL CHEMICAL PATENTS INC. (US) 2025-06-17 US claimed
US-20240373736-A1 Materials and Methods to Improve the Stability of Metal Halide Perovskites THE UNIVERSITY OF TOLEDO (US) 2024-11-07 US claimed
WO-2024038044-A1 PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL BASF SE (DE) 2024-02-22 WO claimed
EP-4281436-A1 SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES BASF SE (DE) 2023-11-29 EP claimed
EP-3732175-B1 A CATALYST COMPOSITION FOR A PRODUCING PROCESS OF AN UNSATURATED CARBOXYLIC ACID SALT AND ITS DERIVATIVES FROM CARBON DIOXIDE AND OLEFIN PTT GLOBAL CHEMICAL PUBLIC CO LTD (TH) 2023-08-16 EP claimed
EP-4132902-A1 PD-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES BASF SE (DE) 2023-02-15 EP claimed
CN-114369085-B Preparation method of Asciminib hydrochloride 武汉九州钰民医药科技有限公司 2023-01-03 CN claimed
CN-115298160-A Pd-catalyzed amination of fluorinated aryl chlorides 巴斯夫欧洲公司 2022-11-04 CN claimed
CN-114369085-A Preparation method of hydrochloric acid Asciminib 武汉九州钰民医药科技有限公司 2022-04-19 CN claimed
EP-2576054-A1 POLYALKYLENE POLYAMINES OBTAINED BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION BASF SE (DE) 2013-04-10 EP claimed
EP-2554547-A1 Transition-metal catalyzed synthesis of diboranes(4) Julius-Maximilians-Universität Würzburg (DE) 2013-02-06 EP claimed
WO-2012158660-A1 PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES EASTMAN KODAK COMPANY (US) 2012-11-22 WO claimed
WO-2012119927-A1 METHOD FOR PRODUCING PRIMARY AMINES OBTAINED BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION BASF SE (DE) 2012-09-13 WO claimed
WO-2012109046-A1 INDIUM PHOSPHIDE COLLOIDAL NANOCRYSTALS EASTMAN KODAK COMPANY (US) 2012-08-16 WO claimed
US-20120205586-A1 INDIUM PHOSPHIDE COLLOIDAL NANOCRYSTALS FPC INC. 2012-08-16 US claimed
EP-2125927-A1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GmbH (DE) 2009-12-02 EP claimed
WO-2008092490-A1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GMBH (DE) 2008-08-07 WO claimed
EP-1951786-A1 PROCESS OF PREPARING REGIOREGULAR POLYMERS Merck Patent GmbH (DE) 2008-08-06 EP claimed
WO-2007059838-A1 PROCESS OF PREPARING REGIOREGULAR POLYMERS MERCK PATENT GMBH (DE) 2007-05-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids RNASEH1, ACE2, DDX42 SHBG 1750/4885ADH1B 536/4885ADH1C 540/4885
US-20240373736-A1 Materials and Methods to Improve the Stability of Metal Halide Perovskites SOD1, BMI1, VCL SHBG 3328/4885ADH1B 2129/4885ADH1C 3217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.